Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

A 22-Year-Old Woman With Systemic Lupus Erythematosus Presents With Two Damaged Kidneys, One Seizure, No Platelets, and Many Possible Diagnoses.

Zickuhr L, Herlitz LC, Chatterjee S.

Arthritis Care Res (Hoboken). 2018 Nov;70(11):1686-1693. doi: 10.1002/acr.23561. No abstract available.

PMID:
29579358
2.

C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.

Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrishnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D'Agati VD, Appel GB.

Kidney Int. 2018 Apr;93(4):977-985. doi: 10.1016/j.kint.2017.10.022. Epub 2018 Jan 6.

PMID:
29310824
3.

Tubulointerstitial Injury and Drugs of Abuse.

Nanavati A, Herlitz LC.

Adv Chronic Kidney Dis. 2017 Mar;24(2):80-85. doi: 10.1053/j.ackd.2016.09.008. Review.

PMID:
28284383
4.

A 31-Year-Old Man With a Ring-Enhancing Brain Lesion.

Riley CS, Roth LA, Sampson JB, Radhakrishnan J, Herlitz LC, Blitz AM, Moazami G.

J Neuroophthalmol. 2017 Jun;37(2):172-175. doi: 10.1097/WNO.0000000000000469. No abstract available.

PMID:
28079760
5.

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.

Stock AD, Wen J, Doerner J, Herlitz LC, Gulinello M, Putterman C.

J Neuroinflammation. 2015 Nov 6;12:205. doi: 10.1186/s12974-015-0423-4.

6.

Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model.

Chan ES, Herlitz LC, Ali J.

J Invest Dermatol. 2015 Sep;135(9):2338-2339. doi: 10.1038/jid.2015.216. Epub 2015 Jul 2. No abstract available.

7.

Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model.

Chan ES, Herlitz LC, Jabbari A.

J Invest Dermatol. 2015 Jul;135(7):1912-1915. doi: 10.1038/jid.2015.107. Epub 2015 Mar 19. No abstract available. Erratum in: J Invest Dermatol. 2015 Sep;135(9):2338-9.

8.

Macrophage depletion ameliorates nephritis induced by pathogenic antibodies.

Chalmers SA, Chitu V, Herlitz LC, Sahu R, Stanley ER, Putterman C.

J Autoimmun. 2015 Feb;57:42-52. doi: 10.1016/j.jaut.2014.11.007. Epub 2014 Dec 29.

9.

Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.

Xia Y, Herlitz LC, Gindea S, Wen J, Pawar RD, Misharin A, Perlman H, Wu L, Wu P, Michaelson JS, Burkly LC, Putterman C.

J Am Soc Nephrol. 2015 May;26(5):1053-70. doi: 10.1681/ASN.2014030233. Epub 2014 Sep 30.

10.

Renal Infections.

Hou J, Herlitz LC.

Surg Pathol Clin. 2014 Sep;7(3):389-408. doi: 10.1016/j.path.2014.04.004. Epub 2014 Jun 26. Review.

PMID:
26837446
11.

Nephrotoxic effects of common and emerging drugs of abuse.

Pendergraft WF 3rd, Herlitz LC, Thornley-Brown D, Rosner M, Niles JL.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1996-2005. doi: 10.2215/CJN.00360114. Epub 2014 Jul 17. Review. Erratum in: Clin J Am Soc Nephrol. 2019 Apr 5;14(4):586.

12.

Rituximab treatment for fibrillary glomerulonephritis.

Hogan J, Restivo M, Canetta PA, Herlitz LC, Radhakrishnan J, Appel GB, Bomback AS.

Nephrol Dial Transplant. 2014 Oct;29(10):1925-31. doi: 10.1093/ndt/gfu189. Epub 2014 May 27.

PMID:
24867652
13.

IgA nephropathy with minimal change disease.

Herlitz LC, Bomback AS, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS.

Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1033-9. doi: 10.2215/CJN.11951113. Epub 2014 Apr 10.

14.

Toward a working definition of C3 glomerulopathy by immunofluorescence.

Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D'Agati VD.

Kidney Int. 2014 Feb;85(2):450-6. doi: 10.1038/ki.2013.340. Epub 2013 Sep 25.

15.

The modern spectrum of renal biopsy findings in patients with diabetes.

Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC, Stokes MB, Markowitz GS, D'Agati VD.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1718-24. doi: 10.2215/CJN.02510213. Epub 2013 Jul 25.

16.

The changing pattern of glomerular disease in HIV and hepatitis C co-infected patients in the era of HAART.

Mohan S, Herlitz LC, Tan J, Cheng JT, Anderson HL, Stokes MB, Markowitz GS, D'Agati VD, Radhakrishnan J.

Clin Nephrol. 2013 Apr;79(4):285-91. doi: 10.5414/CN107774.

PMID:
23320974
17.

BK polyoma virus nephropathy in the native kidney.

Sharma SG, Nickeleit V, Herlitz LC, de Gonzalez AK, Stokes MB, Singh HK, Markowitz GS, D'Agati VD.

Nephrol Dial Transplant. 2013 Mar;28(3):620-31. doi: 10.1093/ndt/gfs537. Epub 2012 Dec 18.

PMID:
23249622
18.

Renal cortical infarction following treatment with sumatriptan in a kidney allograft recipient.

Sharma SG, Post JB, Herlitz LC, Markowitz G.

Am J Kidney Dis. 2013 Feb;61(2):326-9. doi: 10.1053/j.ajkd.2012.07.032. Epub 2012 Dec 1.

PMID:
23206532
19.

Crystalline nephropathies.

Herlitz LC, D'Agati VD, Markowitz GS.

Arch Pathol Lab Med. 2012 Jul;136(7):713-20. doi: 10.5858/arpa.2011-0565-RA. Review.

PMID:
22742545
20.

Pathology after eculizumab in dense deposit disease and C3 GN.

Herlitz LC, Bomback AS, Markowitz GS, Stokes MB, Smith RN, Colvin RB, Appel GB, D'Agati VD.

J Am Soc Nephrol. 2012 Jul;23(7):1229-37. doi: 10.1681/ASN.2011121186. Epub 2012 Jun 7.

21.

Renal biopsy in the elderly and very elderly: useful or not?

Bomback AS, Herlitz LC, Markowitz GS.

Adv Chronic Kidney Dis. 2012 Mar;19(2):61-7. doi: 10.1053/j.ackd.2011.09.003. Review.

PMID:
22449342
22.

The big squeeze: giant cells in granulomatous interstitial nephritis.

Herlitz LC, Zdunek MP, D'Agati VD, Markowitz GS.

Kidney Int. 2011 Aug;80(4):434. doi: 10.1038/ki.2011.187. No abstract available.

23.

ANCA-associated glomerulonephritis in the very elderly.

Bomback AS, Appel GB, Radhakrishnan J, Shirazian S, Herlitz LC, Stokes B, D'Agati VD, Markowitz GS.

Kidney Int. 2011 Apr;79(7):757-64. doi: 10.1038/ki.2010.489. Epub 2010 Dec 15.

24.

Acute kidney injury in the setting of AIDS, bland urine sediment, minimal proteinuria and normal-sized kidneys: a presentation of renal lymphoma.

Sandhu G, Ranade A, Mankal P, Herlitz LC, Jones J, Cortell S.

Nephrol Dial Transplant. 2011 Feb;26(2):747-51. doi: 10.1093/ndt/gfq666. Epub 2010 Nov 4.

PMID:
21051499
25.

Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.

Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS.

Kidney Int. 2010 Dec;78(11):1171-7. doi: 10.1038/ki.2010.318. Epub 2010 Sep 1.

26.

The case: 41-year-old HIV patient with proteinuria and progressive renal dysfunction. Tenofovir toxicity.

Agarwala R, Mohan S, Herlitz LC, Cheng JT.

Kidney Int. 2010 Mar;77(5):475-6. doi: 10.1038/ki.2009.486. No abstract available.

27.

Proliferative glomerulonephritis in lupus patients with human immunodeficiency virus infection: a difficult clinical challenge.

Gindea S, Schwartzman J, Herlitz LC, Rosenberg M, Abadi J, Putterman C.

Semin Arthritis Rheum. 2010 Dec;40(3):201-9. doi: 10.1016/j.semarthrit.2009.12.001. Epub 2010 Feb 4. Review.

PMID:
20132967
28.

Development of focal segmental glomerulosclerosis after anabolic steroid abuse.

Herlitz LC, Markowitz GS, Farris AB, Schwimmer JA, Stokes MB, Kunis C, Colvin RB, D'Agati VD.

J Am Soc Nephrol. 2010 Jan;21(1):163-72. doi: 10.1681/ASN.2009040450. Epub 2009 Nov 16.

29.

Light chain proximal tubulopathy.

Herlitz LC, Roglieri J, Resta R, Bhagat G, Markowitz GS.

Kidney Int. 2009 Oct;76(7):792-7. doi: 10.1038/ki.2008.666. Epub 2009 Jan 21. No abstract available.

30.

A case of nephrocalcinosis.

Herlitz LC, Bruno R, Radhakrishnan J, Markowitz GS.

Kidney Int. 2009 Apr;75(8):856-9. doi: 10.1038/ki.2008.298. Epub 2008 Jul 9. No abstract available.

31.

Nephrogenic adenoma identified on urine cytology using PAX-2 immunostaining.

Herlitz LC, Tong GX, Hamele-Bena D, Greenebaum E.

Diagn Cytopathol. 2008 Jan;36(1):47-9.

PMID:
18064687
32.

Uveitis and acute renal failure.

Herlitz LC, Chun MJ, Stokes MB, Markowitz GS.

Kidney Int. 2007 Dec;72(12):1554-7. Epub 2007 Jul 4. No abstract available.

Supplemental Content

Loading ...
Support Center